SCHEMBL693372

SCHEMBL693372

NC(=O)c1cnn(-c2c(F)cccc2F)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.41
GRM2 Q14416 2/20 0.36
PLAU P00749 1/20 0.35
ELANE P08246 1/20 0.35
SCN9A Q15858 3/20 0.34
MAPK14 Q16539 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ELOVL1 Q9BW60 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
MALT1 Q9UDY8 2/20 0.33
ADAMTS7 Q9UKP4 1/20 0.33
MAPK13 O15264 1/20 0.33
MAPK12 P53778 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15639716 0.85 KDM4E (0.38) PLAUELANEMAPK14KMT2AKDM4E
SCHEMBL15638743 0.83 P2RX7 (0.40) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL15638776 0.80 MAPT (0.39) KMT2AKDM4EALDH1A1MALT1
SCHEMBL15639084 0.78 ELOVL1 (0.33) PLAUELANEELOVL1ADAMTS7
SCHEMBL23367502 0.75 ADAMTS7 (0.44) MAPK14KMT2AKDM4EMEN1ALDH1A1
SCHEMBL6399279 0.75 KDM4E (0.56) GRM2KMT2AKDM4EMEN1ALDH1A1
SCHEMBL15638738 0.74 ALDH1A1 (0.34) KMT2AMEN1ALDH1A1
SCHEMBL694006 0.73 SCN9A (0.44) CA5AGRM2SCN9AELOVL1SCN10A
SCHEMBL15639717 0.72 ELOVL1 (0.35) PLAUELANEKMT2AKDM4EALDH1A1
SCHEMBL29851865 0.71 SCN9A (0.39) SCN9AKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421834-A1 PYRAZOLE AND TRIAZOLE CARBOXAMIDES AS CRAC CHANNEL INHIBITORS Glaxo Group Limited (GB) 2012-02-29 EP claimed
US-11548854-B2 Heterocyclic compounds as pesticides BAYER CROPSCIENCE AG (DE) 2023-01-10 US disclosed
US-20210053924-A1 HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2021-02-25 US disclosed
EP-2421834-A1 PYRAZOLE AND TRIAZOLE CARBOXAMIDES AS CRAC CHANNEL INHIBITORS Glaxo Group Limited (GB) 2012-02-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11548854-B2 Heterocyclic compounds as pesticides DDT, ACHE, PTMS CA5A 1027/4885GRM2 1273/4885PLAU 4408/4885
US-20210053924-A1 HETEROCYCLIC COMPOUNDS AS PESTICIDES DDT, ACHE, PTMS CA5A 1027/4885GRM2 1273/4885PLAU 4408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.